HomeComparePODD vs NKE

PODD vs NKE: Dividend Comparison 2026

PODD yields 0.96% · NKE yields 3.16%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NKE wins by $1.83M in total portfolio value
10 years
PODD
PODD
● Live price
0.96%
Share price
$208.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.0K
Annual income
$102.34
Full PODD calculator →
NKE
NKE
● Live price
3.16%
Share price
$51.24
Annual div
$1.62
5Y div CAGR
66.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.85M
Annual income
$1,337,341.87
Full NKE calculator →

Portfolio growth — PODD vs NKE

📍 NKE pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPODDNKE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PODD + NKE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PODD pays
NKE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PODD
Annual income on $10K today (after 15% tax)
$81.73/yr
After 10yr DRIP, annual income (after tax)
$86.99/yr
NKE
Annual income on $10K today (after 15% tax)
$268.74/yr
After 10yr DRIP, annual income (after tax)
$1,136,740.59/yr
At 15% tax rate, NKE beats the other by $1,136,653.60/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PODD + NKE for your $10,000?

PODD: 50%NKE: 50%
100% NKE50/50100% PODD
Portfolio after 10yr
$936.4K
Annual income
$668,722.10/yr
Blended yield
71.42%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on NKE right now

PODD
Analyst Ratings
36
Buy
10
Hold
3
Sell
Consensus: Buy
Price Target
$357.25
+71.7% upside vs current
Range: $286.00 — $435.00
Altman Z
7.1
Piotroski
7/9
NKE
Analyst Ratings
1
Strong
42
Buy
23
Hold
4
Sell
Consensus: Buy
Price Target
$75.35
+47.1% upside vs current
Range: $62.00 — $110.00
Altman Z
3.8
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PODD buys
0
NKE buys
0
No recent congressional trades found for PODD or NKE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPODDNKE
Forward yield0.96%3.16%
Annual dividend / share$2.00$1.62
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%66.3%
Portfolio after 10y$21.0K$1.85M
Annual income after 10y$102.34$1,337,341.87
Total dividends collected$995.00$1.78M
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary
Analyst consensusBuyBuy
Analyst price target$357.25$75.35

Year-by-year: PODD vs NKE ($10,000, DRIP)

YearPODD PortfolioPODD Income/yrNKE PortfolioNKE Income/yrGap
1← crossover$10,796$96.15$11,226$525.77$430.00NKE
2$11,649$97.01$12,929$917.32$1.3KNKE
3$12,562$97.83$15,476$1,642.01$2.9KNKE
4$13,540$98.60$19,614$3,054.78$6.1KNKE
5$14,587$99.32$27,004$6,017.26$12.4KNKE
6$15,708$100.00$41,770$12,875.77$26.1KNKE
7$16,909$100.64$75,648$30,954.02$58.7KNKE
8$18,193$101.24$168,071$87,127.77$149.9KNKE
9$19,569$101.81$480,693$300,856.83$461.1KNKE
10$21,041$102.34$1,851,684$1,337,341.87$1.83MNKE

PODD vs NKE: Complete Analysis 2026

PODDStock

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Full PODD Calculator →

NKEConsumer Discretionary

NIKE, Inc., together with its subsidiaries, designs, develops, markets, and sells men's, women's, and kids athletic footwear, apparel, equipment, and accessories worldwide. The company provides athletic and casual footwear, apparel, and accessories under the Jumpman trademark; and casual sneakers, apparel, and accessories under the Converse, Chuck Taylor, All Star, One Star, Star Chevron, and Jack Purcell trademarks. In addition, it sells a line of performance equipment and accessories comprising bags, socks, sport balls, eyewear, timepieces, digital devices, bats, gloves, protective equipment, and other equipment for sports activities under the NIKE brand; and various plastic products to other manufacturers. The company markets apparel with licensed college and professional team, and league logos, as well as sells sports apparel. Additionally, it licenses unaffiliated parties to manufacture and sell apparel, digital devices, and applications and other equipment for sports activities under NIKE-owned trademarks. The company sells its products to footwear stores; sporting goods stores; athletic specialty stores; department stores; skate, tennis, and golf shops; and other retail accounts through NIKE-owned retail stores, digital platforms, independent distributors, licensees, and sales representatives. The company was formerly known as Blue Ribbon Sports, Inc. and changed its name to NIKE, Inc. in 1971. NIKE, Inc. was founded in 1964 and is headquartered in Beaverton, Oregon.

Full NKE Calculator →
📬

Get this PODD vs NKE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PODD vs SCHDPODD vs JEPIPODD vs OPODD vs KOPODD vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.